Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection

A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in cardiology 2021-08, Vol.2021, p.1-3
Main Authors: Ocher, Rebecca A., Padilla, Erika, Hsu, Jonathan C., Taub, Pam R.
Format: Article
Language:English
Subjects:
Ablation
Blood pressure
Cardiac arrhythmia
Cardiology
Case Report
Case reports
Coronaviruses
COVID-19
Heart rate
Infections
Laboratories
Monitoring systems
Nervous system
Pacemakers
Pathophysiology
Patients
Severe acute respiratory syndrome coronavirus 2
Sinuses
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors’ knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients.
ISSN:2090-6404
2090-6412
DOI:10.1155/2021/7809231